(Q52026807)

20 April 2018

title

A long-term follow-up study of cerebrospinal fluid somatostatin in delirium. (English)

1 reference

20 April 2018

0 references

Koponen HJ

1

1 reference

20 April 2018

Leinonen E

series ordinal

2

1 reference

20 April 2018

Lepola U

series ordinal

3

1 reference

20 April 2018

Riekkinen PJ

series ordinal

4

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 May 1994

1 reference

20 April 2018

Acta Psychiatrica Scandinavica

published in

1 reference

20 April 2018

volume

89

1 reference

20 April 2018

issue

5

1 reference

20 April 2018

page(s)

329-334

1 reference

20 April 2018

Transient cognitive disorders (delirium, acute confusional states) in the elderly.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Somatostatin is increased in the basal ganglia in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Preclinical and clinical studies with somatostatin related to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Somatostatin effects on the cyclic AMP system and lipid metabolism in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Somatostatin selectively enhances acetylcholine-induced excitations in rat hippocampus and cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

CSF Somatostatin in Affective Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

CSF somatostatin-like immunoreactivity in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Patients with Alzheimer's disease show an increased content of 15 Kdalton somatostatin precursor and a lowered level of tetradecapeptide in their cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Delirium (acute confusional states).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Positron emission tomography in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Neuropeptides in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Effects of carbamazepine on cerebrospinal fluid somatostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Effects of haloperidol on somatostatin-like immunoreactivity in the CSF of Schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01524.X

10.1111/J.1600-0447.1994.TB01524.X

21 January 2018

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018